Correlation Between Passage Bio and Pieris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Passage Bio and Pieris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Passage Bio and Pieris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Passage Bio and Pieris Pharmaceuticals, you can compare the effects of market volatilities on Passage Bio and Pieris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Passage Bio with a short position of Pieris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Passage Bio and Pieris Pharmaceuticals.
Diversification Opportunities for Passage Bio and Pieris Pharmaceuticals
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Passage and Pieris is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and Pieris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pieris Pharmaceuticals and Passage Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Passage Bio are associated (or correlated) with Pieris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pieris Pharmaceuticals has no effect on the direction of Passage Bio i.e., Passage Bio and Pieris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Passage Bio and Pieris Pharmaceuticals
Given the investment horizon of 90 days Passage Bio is expected to under-perform the Pieris Pharmaceuticals. In addition to that, Passage Bio is 3.58 times more volatile than Pieris Pharmaceuticals. It trades about 0.0 of its total potential returns per unit of risk. Pieris Pharmaceuticals is currently generating about -0.01 per unit of volatility. If you would invest 1,700 in Pieris Pharmaceuticals on August 28, 2024 and sell it today you would lose (16.00) from holding Pieris Pharmaceuticals or give up 0.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Passage Bio vs. Pieris Pharmaceuticals
Performance |
| Timeline |
| Passage Bio |
| Pieris Pharmaceuticals |
Passage Bio and Pieris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Passage Bio and Pieris Pharmaceuticals
The main advantage of trading using opposite Passage Bio and Pieris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Passage Bio position performs unexpectedly, Pieris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pieris Pharmaceuticals will offset losses from the drop in Pieris Pharmaceuticals' long position.| Passage Bio vs. Black Diamond Therapeutics | Passage Bio vs. Revolution Medicines | Passage Bio vs. Stoke Therapeutics | Passage Bio vs. Cabaletta Bio |
| Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |